UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000038993 |
|---|---|
| Receipt number | R000044462 |
| Scientific Title | Usefulness of max body height as a muscular index in the relationship between osteoporosis and sarcopenia: A retrospective study |
| Date of disclosure of the study information | 2019/12/25 |
| Last modified on | 2019/12/25 14:02:32 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Usefulness of max body height as a muscular index in the relationship between osteoporosis and sarcopenia: A retrospective study
Acronym
Usefulness of max body height as a muscular index in the relationship between osteoporosis and sarcopenia: A retrospective study
Scientific Title
Usefulness of max body height as a muscular index in the relationship between osteoporosis and sarcopenia: A retrospective study
Scientific Title:Acronym
Usefulness of max body height as a muscular index in the relationship between osteoporosis and sarcopenia: A retrospective study
Region
| Japan |
Condition
Condition
Sarcopenia, Osteoporosis
Classification by specialty
| Endocrinology and Metabolism | Geriatrics |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
We aim to clarify usefulness of max body height as a muscular index in the relationship between osteoporosis and sarcopenia.
Basic objectives2
Others
Basic objectives -Others
We aim to clarify usefulness of max body height as a muscular index in the relationship between osteoporosis and sarcopenia.
Trial characteristics_1
Others
Trial characteristics_2
Others
Developmental phase
Not applicable
Assessment
Primary outcomes
Usefulness of max body height as a muscular index in sarcopenia.
Key secondary outcomes
Usefulness of max body height as a muscular index in the relationship between osteoporosis and sarcopenia.
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 100 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1.Patients admitted to Shimane University Hospital for evaluation and treatment of sarcopenia and osteoporosis between 2014 and 2019.
2.Patients evaluated BMD, presence of vertebral fracture and muscle mass.
Key exclusion criteria
no exclusion criteria
Target sample size
500
Research contact person
Name of lead principal investigator
| 1st name | Ken-ichiro |
| Middle name | |
| Last name | Tanaka |
Organization
Shimane University
Division name
Internal medicine 1
Zip code
693-8501
Address
89-1 Enyacho, Izumo, Shimane
TEL
0853-20-2183
ken1nai@med.shimane-u.ac.jp
Public contact
Name of contact person
| 1st name | Ken-ichiro |
| Middle name | |
| Last name | Tanaka |
Organization
Shimane University
Division name
Internal medicine 1
Zip code
693-8501
Address
89-1 Enyacho, Izumo, Shimane
TEL
0853-20-2183
Homepage URL
ken1nai@med.shimane-u.ac.jp
Sponsor or person
Institute
Shimane University
Institute
Department
Personal name
Funding Source
Organization
Shimane University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Shimane University
Address
89-1 Enyacho, Izumo, Shimane
Tel
0853-20-2183
ken1nai@med.shimane-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 12 | Month | 25 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2019 | Year | 12 | Month | 25 | Day |
Date of IRB
Anticipated trial start date
| 2019 | Year | 12 | Month | 25 | Day |
Last follow-up date
| 2020 | Year | 12 | Month | 25 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Nothing in particular
Management information
Registered date
| 2019 | Year | 12 | Month | 25 | Day |
Last modified on
| 2019 | Year | 12 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044462
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
